Current Opinion in Endocrinology, Diabetes and Obesity 20 6 : Endocr Pract ; — A cross-sectional study. Lesbian, gay, bisexual, and transgender-related content in undergraduate medical education. J Am Med Assoc ; — Safer JD, Tangpricha V.
Papillon Center - Dr. McGinn SRS, HRT, and Electrolysis
Transgender hormone therapy of the male-to-female MTF type, also known as transfeminine hormone therapy , is hormone therapy and sex reassignment therapy to change the secondary sexual characteristics of transgender people from masculine or androgynous to feminine. Some intersex people also take this form of therapy, according to their personal needs and preferences. The purpose of the therapy is to cause the development of the secondary sex characteristics of the desired sex , such as breasts and a feminine pattern of hair , fat , and muscle distribution. It cannot undo many of the changes produced by naturally occurring puberty , which may necessitate surgery and other treatments to reverse see below. The medications used for the MTF therapy include estrogens , antiandrogens , progestogens , and gonadotropin-releasing hormone modulators GnRH modulators. While the therapy cannot undo the effects of a person's first puberty , developing secondary sex characteristics associated with one's gender has been shown to relieve some or all of the distress and discomfort associated with gender dysphoria , and can help the person to "pass" or be seen as their gender. The goal of the therapy is to provide patients with a more satisfying body that is more congruent with their gender identity.
Transgender Health Specialist
Transgender women on hormone therapy may be at a higher risk for cardiovascular problems, such as stroke, blood clots and heart attack, researchers reported Monday. The study was done by reviewing eight years of medical records of nearly 5, transgender patients in the Kaiser Health system, and looked at patients over the age of 18 who took hormones for gender transition. Over 97, cisgender patients — people whose sex assigned at birth matches their gender identity — with similar age and health characteristics were studied for comparison.
Transgender hormone therapy THT involves the taking of estrogen or testosterone hormones to induce a gender reassignment. THT allows a psychological transition from one gender to another female to male, or male to female , and an anatomical transition from one sex to another woman to man, or man to woman. THT is typically prescribed for individuals undergoing gender-identity disorders, or when a provider and patient mutually agree upon a request for gender reassignment. In the U. Mainly targeting the endocrine system, hormone therapy promotes the control of sex and gender characteristics such as: the development of breasts, facial hair, and reproductive systems.